Key result
Sodium-glucose cotransporter-2 inhibitors and their effect on stroke risk in patients with atrial fibrillation are discussed in this commentary, which presents no new clinical data.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Tayebi et al. (2025) studied this question. Sodium-glucose cotransporter-2 inhibitors and their effect on stroke risk in patients with atrial fibrillation are discussed in this commentary, which presents no new clinical data.
Synapse has enriched 10 related papers. Consider them for comparative context: